Biostem Technologies Correlations
| BSEM Stock | USD 15.49 0.49 3.27% |
The current 90-days correlation between Biostem Technologies and Erytech Pharma SA is -0.2 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biostem Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biostem Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Biostem Technologies Correlation With Market
Significant diversification
The correlation between Biostem Technologies and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biostem Technologies and DJI in the same portfolio, assuming nothing else is changed.
Biostem |
The ability to find closely correlated positions to Biostem Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biostem Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biostem Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biostem Technologies to buy it.
Moving against Biostem OTC Stock
| 0.63 | SGEN | Seagen Inc | PairCorr |
| 0.54 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.44 | VZ | Verizon Communications Fiscal Year End 28th of January 2025 | PairCorr |
| 0.43 | KO | Coca Cola Fiscal Year End 11th of February 2025 | PairCorr |
| 0.42 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.36 | PG | Procter Gamble | PairCorr |
| 0.32 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Biostem OTC Stock performing well and Biostem Technologies OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biostem Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GNFT | 2.12 | (0.49) | 0.00 | (1.12) | 0.00 | 3.55 | 22.25 | |||
| CYT | 2.76 | 0.57 | 0.16 | (2.31) | 2.57 | 10.00 | 36.14 | |||
| ERYP | 4.72 | (0.09) | 0.00 | 0.47 | 0.00 | 12.68 | 46.27 | |||
| ELYM | 3.62 | (1.09) | 0.00 | (1.67) | 0.00 | 6.00 | 22.16 | |||
| HCWB | 12.16 | 2.86 | 0.30 | 0.75 | 7.38 | 10.00 | 352.85 | |||
| MTCR | 1.96 | 0.43 | 0.17 | 2.72 | 1.42 | 6.00 | 11.05 | |||
| MGTA | 2.62 | 0.11 | 0.03 | (0.50) | 3.40 | 5.88 | 16.99 | |||
| TARA | 5.78 | 2.29 | 0.44 | (30.76) | 3.83 | 13.00 | 78.24 | |||
| STSA | 3.39 | 0.50 | 0.12 | (1.58) | 3.54 | 5.71 | 70.12 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biostem Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Biostem Technologies Corporate Management
Elected by the shareholders, the Biostem Technologies' board of directors comprises two types of representatives: Biostem Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biostem. The board's role is to monitor Biostem Technologies' management team and ensure that shareholders' interests are well served. Biostem Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biostem Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Irmgard MD | International Officer | Profile | |
| Larry Jones | Chief Officer | Profile | |
| Michael CPA | Chief Officer | Profile | |
| David Woynarowski | Chief Officer | Profile |